Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
HN.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.16.29NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.1.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.11.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GK.1.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.3.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GL.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CM.8.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.26NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.3.14NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBC.1.6.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GW.5.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KC.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.3.10NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FY.5.5.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DV.6.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FK.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HF.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.31NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HG.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.4.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.9.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FY.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDBNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GA.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.35NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GM.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.44NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FU.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FV.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GJ.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.16.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.22.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FE.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBL.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.56NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.16.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.1.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.49NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBL.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FR.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.17NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.2.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.1.10NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.3.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDDNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.53NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used